Publication | Closed Access

Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus–associated head and neck squamous cell carcinoma?

PathologyCancer-associated VirusOncologyCancer DetectionHuman Papillomavirus VaccinesNeck OncologyMolecular DiagnosticsRadiation OncologyCancer ResearchHealth SciencesCost-effective MethodCancer DiagnosisP16 ImmunohistochemistryMolecular Diagnostic TechniquesHead And Neck CancerHead And Neck Squamous Cell CarcinomaMedicineCancer TherapeuticsCytopathologyHuman Papilloma